Buy custom Repositioning Ranbaxy

Essay's paper info

Essay's paper body

Indian companies will rise to the occasion

• Change in focus toward developing new drugs

o Looking to enter developed markets

o New plants to comply with international regulations (FDA)

o Implementation of Total Quality Management in all plants

• Global Expansion with acquisition of overseas labs
• Drastic increase in R&D investment to about 5% of sales (focused on new drug development)
• High capacity utilization for Bulk drugs (92%) compared to Formulation drugs (62%)
• Same approach for both developing and developed markets in spite of different costs

Response to Liberalization

• Same quality for both developed and developing markets a jump in fixed assets in 1991
• Increased investment in intangibles- HR, Quality control, IT, TQM
• Relationship with vendors a fall in rejection rates
• International manufacturing plants to manufacture dosage forms a manufacturing presence in all 4 regions
• 9% of sales on marketing but mostly successful in India alone
• Current R&D concentrated on producing generic versions of existing drugs
• R&D costs much lower in India (Personnel and Machinery) and reduced cycle time by 2 years

Recommendations

• Could consider JV only for R&D purposes and not manufacturing
• Could focus on selling bulk drugs before major investments in overseas plants
• Choosing the right match between products and markets that would give it economies of scale and scope

We think that they cannot change their strategy all of a sudden from selling Bulk drugs to making new drugs...

Indian companies will rise to the occasion

• Change in focus toward developing new drugs

o Looking to enter developed markets

o New plants to comply with international regulations (FDA)

o Implementation of Total Quality Management in all plants

• Global Expansion with acquisition of overseas labs
• Drastic increase in R&D investment to about 5% of sales (focused on new drug development)
• High capacity utilization for Bulk drugs (92%) compared to Formulation drugs (62%)
• Same approach for both developing and developed markets in spite of different costs

Response to Liberalization

• Same quality for both developed and developing markets a jump in fixed assets in 1991
• Increased investment in intangibles- HR, Quality control, IT, TQM
• Relationship with vendors a fall in rejection rates
• International manufacturing plants to manufacture dosage forms a manufacturing presence in all 4 regions
• 9% of sales on marketing but mostly successful in India alone
• Current R&D concentrated on producing generic versions of existing drugs
• R&D costs much lower in India (Personnel and Machinery) and reduced cycle time by 2 years

Recommendations

• Could consider JV only for R&D purposes and not manufacturing
• Could focus on selling bulk drugs before major investments in overseas plants
• Choosing the right match between products and markets that would give it economies of scale and scope

We think that they cannot change their strategy all of a sudden from selling Bulk drugs to making new drugs...

General points of the essay

How the Use of Drugs and Alcohol Affect High School Achievement Bond Markets, the next big investment vehicle in India Cellular phone companies in developing markets Choosing Candidate Markets And Products When A Firm Goes International Cultural Change in International Markets Developing Partner In Emerging Markets Local Flavours Heat Up Meal Solutions In Developing Markets Gore Vidal, DRUGS - response War on Drugs Should Focus on Traffickers Drugs: A Major Problem In Canadian Society Selling Drugs for Fun and Profit The Global Threat of Drugs The High Price Of Drugs In America teenagers and drugs in high schools With reference to both legal and illegal drugs, critically assess the casual relationship between drugs and crime?

Essays related to the topic